Trials / Completed
CompletedNCT00621959
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine 5 mg Once Daily Given for 2 Weeks in Subjects 18 yr of Age and Older With Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 596 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to investigate the efficacy of levocetirizine in reducing symptoms associated with seasonal allergic rhinitis and in improving rhinitis-related Quality of Life
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine dihydrochloride | 5mg daily (oral tablet) for 14 days |
| DRUG | placebo | 0mg (matching oral tablet)for 14 days |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-02-22
- Last updated
- 2020-07-16
- Results posted
- 2009-08-06
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00621959. Inclusion in this directory is not an endorsement.